Neurotoxin market to reach $12.43 billion by 2030 at 9.1% cagr, driven by surge in cosmetic procedures to improve appearance.
Read More
Neuroregeneration therapy market to reach $20.5 billion by 2030 at 12.6% cagr, driven by rising prevalence of neurological disorders and aging population.
Read More
Neuromuscular blocking drug market to reach $5.23 billion by 2030 at 5.0% cagr, driven by increasing number of surgical procedures.
Read More
Neurological disorder drugs market to reach $116.27 billion by 2030 at 5.3% cagr, driven by increasing prevalence of neurological diseases.
Read More
Neurogenic detrusor overactivity market to reach $2.63 billion by 2030 at 7.6% cagr, driven by rising incidence of neurological disorders.
Read More
Neurodegenerative disorder therapeutics market to reach $34.13 billion by 2030 at 9.6% cagr, driven by increasing investment in research and development.
Read More
Neurodegenerative disease market to reach $88.5 billion by 2030 at 9.0% cagr, driven by increase in research and clinical trials.
Read More
Netupitant-palonosetron fdc market to reach $608.99 billion by 2030 at 9.6% cagr, driven by increasing prevalence of cancer.
Read More
Nerve growth factor market to reach $1.71 billion by 2030 at 7.6% cagr, driven by increasing prevalence of neurological disorders.
Read More
Nephrology drugs market to reach $24.32 billion by 2030 at 6.7% cagr, driven by rising prevalence of chronic kidney disease.
Read More